Flagship Pioneering as of June 30, 2022
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 12 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 69.4 | $1.8B | 13M | 142.85 | |
| Sana Biotechnology (SANA) | 8.3 | $220M | 34M | 6.43 | |
| Foghorn Therapeutics (FHTX) | 6.5 | $172M | 13M | 13.60 | |
| Evelo Biosciences | 4.0 | $106M | 50M | 2.10 | |
| Omega Therapeutics (OMGAQ) | 3.7 | $98M | 26M | 3.80 | |
| Denali Therapeutics (DNLI) | 2.9 | $77M | 2.6M | 29.43 | |
| Seres Therapeutics | 1.9 | $49M | 14M | 3.43 | |
| Axcella Health Inc equity | 1.4 | $38M | 19M | 2.03 | |
| Rubius Therapeutics | 1.2 | $33M | 39M | 0.85 | |
| Sigilon Therapeutics | 0.3 | $8.6M | 10M | 0.83 | |
| Codiak Biosciences | 0.3 | $7.5M | 2.6M | 2.88 | |
| Syros Pharmaceuticals | 0.1 | $2.8M | 2.9M | 0.96 |
